Medicare Enrolled

Dr. Kamesh Sivagnanam, MD

Cardiovascular Disease · Harlingen, TX
Practice pattern: Cardiac & Remote— Practice combining cardiac and remote services
Low-engagement
2121 PEASE ST STE 406, Harlingen, TX 78550
9563895677
In practice since 2011 (15 years)
NPI: 1396043055 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Sivagnanam from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sivagnanam? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Sivagnanam

Dr. Kamesh Sivagnanam is a cardiovascular disease in Harlingen, TX, with 15 years in practice. Based on federal Medicare data, Dr. Sivagnanam performed 1,873 Medicare services across 1,331 unique beneficiaries.

Between the years covered by Open Payments, Dr. Sivagnanam received a total of $6,070 from 18 pharmaceutical and/or device companies across 186 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Sivagnanam is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 15 years in practice▲ 1,873 Medicare services$ $6,070 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,873
Medicare services
Bottom 48% in TX for cardiovascular disease
1,331
Unique beneficiaries
$66
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~125 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (30-39 min)254$79$306
Regadenoson injection (Lexiscan) for heart stress test160$47$196
Hospital follow-up visit, moderate complexity148$60$208
Office visit, established patient, complex (40-54 min)128$118$412
Hospital follow-up visit, high complexity120$88$300
Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec114$28$81
Initial hospital admission, moderate complexity84$94$394
Electrocardiogram (EKG), 12-lead72$9$57
Technetium tc-99m tetrofosmin, diagnostic, per study dose68$91$365
Echocardiogram, transthoracic66$120$719
Evaluation of cardiac rhythm monitor system, remote up to 30 days64$15$85
New patient office visit (45-59 min)50$92$465
Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days49$16$74
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician45$46$221
Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional39$19$78
Nuclear medicine studies of heart muscle at rest and with stress and spect36$271$1,366
Remote pacemaker/defibrillator monitoring, 90 days35$13$97
Remote pacemaker monitoring, 90 days31$18$105
EKG interpretation and report29$6$25
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician26$13$71
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician26$9$47
Complete ultrasound study of arm and leg arteries26$70$494
Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring25$6$88
Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional25$17$79
Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes24$9$36
Ultrasound of heart, follow-up22$19$84
Ultrasound of both sides of head and neck blood flow22$108$560
Programming of dual lead pacemaker system21$53$184
Initial hospital admission, high complexity16$133$565
Smoking and tobacco use intensive counseling, 4-10 minutes13$14$38
Ultrasound study of arm or leg veins with compression and maneuvers12$104$672
New patient office visit, complex (60-74 min)12$151$587
Cardiac catheterization11$213$890
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
8.8% high complexity
20.0% medium
71.2% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$6,070
Total received (2018-2024)
Avg $867/year across 7 years
Top 44% in TX for cardiovascular disease
18
Companies
186
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,870 (96.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$201 (3.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,289
2023
$22
2022
$1,419
2021
$962
2020
$553
2019
$461
2018
$1,364

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Medtronic, Inc.
$1,442
Abbott Laboratories
$1,429
GE Healthcare
$973
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$677
AstraZeneca Pharmaceuticals LP
$573
Janssen Pharmaceuticals, Inc
$281
Novartis Pharmaceuticals Corporation
$215
PFIZER INC.
$201
Boehringer Ingelheim Pharmaceuticals, Inc.
$90
Medtronic Vascular, Inc.
$33
SANOFI-AVENTIS U.S. LLC
$30
Biocompatibles, Inc.
$24
PORTOLA PHARMACEUTICALS, LLC
$20
E.R. Squibb & Sons, L.L.C.
$20
Cardinal Health 200, LLC
$19
PORTOLA PHARMACEUTICALS, INC.
$19
Amarin Pharma Inc.
$13
Lundbeck LLC
$11
Top 3 companies account for 63.3% of total payments
Associated products mentioned in payments ›
ANDEXXA · AVEIR · Azure · BRILINTA · CARDIOMEMS · CHANTIX · ELIQUIS · ENTRESTO · FARXIGA · GALLANT · JARDIANCE · JOT DX · LifeVest · MERLIN@HOME · Micra · Mitra Clip system · MynxGrip Vascular Closure Device · NORTHERA · PRADAXA · PRALUENT · VARITHENA · VENASEAL · Vascepa · Visia AF · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $324 per 100 Medicare services performed
Looking for a cardiovascular disease in Harlingen?
Compare cardiovascular diseases in the Harlingen area by procedure volume, costs, and industry payment transparency.
Browse cardiovascular diseases nearby

Geographic Context

Cardiovascular Diseases within 10 mi
20
Per 100K population
4.7
County median income
$51,334
Nearest hospital
VHS HARLINGEN HOSPITAL COMPANY LLC
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Sivagnanam is a cardiac & remote specialist, with moderate Medicare volume, and low-engagement industry engagement, with 15 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Sivagnanam experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Sivagnanam performed 254 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Sivagnanam receive payments from pharmaceutical companies?
Yes. Dr. Sivagnanam received a total of $6,070 from 18 companies across 186 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sivagnanam's costs compare to other cardiovascular diseases in Harlingen?
Dr. Sivagnanam's average Medicare payment per service is $66. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sivagnanam) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →